法国生殖支原体与阴道毛滴虫感染点患病率研究
该研究在2014年9月至2015年1月期间,从法国16所大学医院收集了2652份连续的泌尿生殖道标本,用于检测沙眼衣原体和淋病奈瑟菌,并采用商业化实时PCR试剂盒评估生殖支原体和阴道毛滴虫的患病率。结果显示,阴道毛滴虫和生殖支原体患病率分别为1.7%(95%CI 1.3-2.4)和3.4%(95%CI 2.8-4.2),生殖支原体在性传播感染门诊等高危行为患者中患病率更高(4.0% vs 1.7%,p 0.009),且多数阳性患者无症状(生殖支原体70.9%,阴道毛滴虫61.5%)。
要点
- 法国阴道毛滴虫患病率低(1.7%),不支持系统性筛查。
- 生殖支原体患病率3.4%,在高危行为患者中更高(4.0% vs 1.7%)。
- 多数生殖支原体和阴道毛滴虫阳性患者无症状。
核心结论
- 法国阴道毛滴虫患病率低,不支持系统筛查;生殖支原体可在接收高危性行为患者的机构中进行选择性筛查,无论症状如何。
研究设计与样本
- 多中心研究,2014年9月至2015年1月收集法国16所大学医院2652份连续泌尿生殖道标本,采用商业化实时PCR检测生殖支原体和阴道毛滴虫,匿名收集临床数据。
主要发现
- 阴道毛滴虫患病率为1.7%(95%CI 1.3-2.4),生殖支原体患病率为3.4%(95%CI 2.8-4.2)。
- 生殖支原体患病率在35-44岁年龄组男性与女性间差异有统计学意义(5.9% vs 1.5%,p 0.03)。
- 生殖支原体在性传播感染门诊、流产中心、计划生育门诊和监狱的患者中患病率显著高于妇科、产科和生殖中心(4.0% vs 1.7%,p 0.009)。
- 生殖支原体和阴道毛滴虫阳性患者中分别有70.9%和61.5%无症状。
临床怎么用
- 在法国,不建议对阴道毛滴虫进行系统筛查。
- 对于性传播感染门诊、流产中心、计划生育门诊和监狱等机构就诊的患者,可考虑选择性筛查生殖支原体,无论有无症状。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mycoplasma genitalium and Trichomonas vaginalis are common causes of sexually transmitted infections, but limited prevalence data are available in France. We aimed to evaluate the prevalence of M. genitalium and T. vaginalis infections and to assess prevalence by gender, age, sample collection sites and clinical symptoms. A multicentre collection of specimens was intended to obtain a nationwide overview of the epidemiology. METHODS: Between September 2014 and January 2015, a total of 2652 consecutive urogenital specimens submitted to the microbiology diagnostic departments of 16 French university hospitals for Chlamydia trachomatis and Neisseria gonorrhoeae detection were collected. M. genitalium and T. vaginalis prevalence were evaluated using a commercial real-time PCR kit. Clinical data from patients were anonymously collected. RESULTS: T. vaginalis and M. genitalium prevalence were 1.7% (95% confidence interval 1.3-2.4) and 3.4% (95% confidence interval 2.8-4.2), respectively, and did not differ between gender or age groups, except M. genitalium prevalence between men and women in the 35- to 44-year age group (5.9 vs. 1.5%; p 0.03). M. genitalium prevalence was significantly higher in patients receiving care in sexually transmitted infection clinics, abortion centres, family planning clinics and prisons than in gynaecologic, obstetric and reproduction centres (4.0 vs. 1.7%, p 0.009). Among M. genitalium- and T. vaginalis-positive patients, 70.9 and 61.5% were asymptomatic, respectively. CONCLUSIONS: The low T. vaginalis prevalence does not justify systematic screening for this organism in France. Conversely, selective screening for M. genitalium may be warranted in care settings that receive presumably high-risk sexual behaviour patients, regardless of symptoms.
引用
- Pereyre S, Laurier Nadalié C, Bébéar C, et al. Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases. Clin Microbiol Infect. 2016. PMID: 27836808. doi:10.1016/j.cmi.2016.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。